Natural Capsules Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹48.71 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹48.71 crore. This corresponds to a year-on-year *(YoY) decline of 16.66 per cent.
Operating Profit
Operating Profit stands at ₹1.12 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹1.12 crore. This corresponds to a year-on-year *(YoY) decline of 15.79 per cent.
PBDT
PBDT stands at ₹-1.51 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹-1.51 crore. This corresponds to a year-on-year *(YoY) decline of 88.75 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-5.84 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹-5.84 crore. This corresponds to a year-on-year *(YoY) decline of 14.96 per cent.
Net Profit
Net Profit stands at ₹-5.75 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹-5.75 crore. This represents a 15.46 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Natural Capsules Ltd Earnings
- YOY
- QOQ
Natural Capsules Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Natural Capsules Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Natural Capsules Ltd Financial Reports
Natural Capsules Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Natural Capsules | -3.98% | 2.31% | 44.08% | 38.25% | 43.69% | 3.48% |
| Nectar Lifesci. | 0.74% | -2.16% | 17.61% | 5.71% | 3.56% | -13.76% |
| Kerala Ayurveda | 4.97% | 5.31% | 16.35% | 7.24% | -14.75% | -62.40% |
| Sanjiv.Parant. | -0.21% | -1.48% | -6.42% | 28.67% | 11.53% | -22.86% |
| Novelix Pharma. | -3.71% | -7.21% | 3.84% | 9.92% | 36.67% | 86.98% |
| Coral Labs. | -1.88% | -7.74% | 2.87% | 15.52% | 32.70% | 14.08% |
| Oxygenta Pharma | -3.13% | -3.39% | 4.57% | 7.86% | 7.08% | -25.62% |
Company Info
Company Information
Chairman & Independent Directo : T Y Prabhu
Executive Director & MD : Sunil L Mundra
E D & Wholetime Director : Satyanarayan Mundra
E D & Wholetime Director : Laxminarayan Moondra
Non-Exec & Non-Independent Dir : Sushil Kumar Mundra
Independent Non Exe. Director : Pramod Kasat
Non-Exec & Non-Independent Dir : Jyothi Mundra
Independent Non Exe. Director : Shirish Gundopant Belapure
Company Sec. & Compli. Officer : Akshay Dutta